spironolactone has been researched along with Myasthenia Gravis in 31 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
Excerpt | Relevance | Reference |
---|---|---|
"Our study confirms pregnancy is more difficult to manage at the beginning of MG." | 1.33 | [Myasthenia gravis and pregnancy: clinical course and management of delivery and the postpartum phase]. ( de Seze, J; Defebvre, L; Delalande, S; Delrieu, O; Destée, A; Fourrier, F; Leys, D; Ramirez, C; Stojkovic, T; Vermersch, P, 2006) |
"The diagnosis of myasthenia gravis is often difficult and calls for a broader use of pharmacological and electrodiagnostic tests." | 1.24 | MYASTHENIA GRAVIS: MEDICAL ASPECTS. ( BUCKLER, WS; ZELDOWICZ, LR, 1965) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 30 (96.77) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (3.23) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
GOTTLIEB, B | 1 |
LAURENT, LP | 1 |
RAVINA, A | 1 |
FARDEAU, M | 1 |
SATOYOSHI, E | 1 |
MURAKAMI, K | 1 |
OKAZAKI, T | 1 |
COSSA, P | 1 |
MAMOU, H | 1 |
MORGENSTEIN, S | 1 |
LAPRESLE, J | 1 |
BOUDIN, G | 1 |
GOULON, M | 3 |
HAMBURGER, J | 1 |
LHERMITTE, F | 1 |
PEQUIGNOT, H | 1 |
LEFEVRE, JP | 1 |
FERRARI, G | 1 |
VIO, M | 1 |
ZELDOWICZ, LR | 1 |
BUCKLER, WS | 1 |
JEUNE, M | 1 |
VINCENT, P | 1 |
HUMBERT, G | 1 |
LEVRAT, R | 1 |
PIETTE, Y | 1 |
VERHELST, S | 1 |
PLAUCHU, M | 1 |
DALMAIS, J | 1 |
BUSSY, L | 1 |
TETE, R | 1 |
MOULINIER, B | 1 |
Ramirez, C | 1 |
de Seze, J | 1 |
Delrieu, O | 1 |
Stojkovic, T | 1 |
Delalande, S | 1 |
Fourrier, F | 1 |
Leys, D | 1 |
Defebvre, L | 1 |
Destée, A | 1 |
Vermersch, P | 1 |
Lincke, HO | 1 |
Yamada, S | 1 |
Ishii, Y | 1 |
Noguchi, H | 1 |
Ohara, H | 1 |
Brun, J | 1 |
Magnin, F | 1 |
von Reis, G | 2 |
Liljestrand, A | 2 |
Matell, G | 2 |
Oosterhuis, HJ | 2 |
Takahashi, A | 1 |
Henriquet, F | 1 |
Balestra, L | 1 |
Barois, A | 2 |
Gajdos, P | 1 |
Grosbuis, S | 2 |
Joron, MH | 2 |
Bennaiche, M | 1 |
Nouailhat, F | 1 |
van der Slooten, EP | 1 |
Gościńska, Z | 1 |
Kusiak-Dadak, M | 1 |
Miezyński, W | 1 |
Petryk, O | 1 |
Rokosz, A | 1 |
Nakamoto, M | 1 |
Sepe, O | 1 |
Stöber, G | 1 |
Poppe, W | 1 |
Sassi, D | 1 |
1 review available for spironolactone and Myasthenia Gravis
Article | Year |
---|---|
[ACTH or adrenocortical hormone therapy in myasthenia gravis, myotonia and herpes zoster].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Herpes Zoster; Humans; Myasthenia Gravis; Myot | 1968 |
1 trial available for spironolactone and Myasthenia Gravis
Article | Year |
---|---|
[Evaluation of the effect of spinonolactone on myasthenia gravis using a double blind test].
Topics: Adult; Cholinesterase Inhibitors; Female; Humans; Myasthenia Gravis; Placebos; Spironolactone | 1967 |
29 other studies available for spironolactone and Myasthenia Gravis
Article | Year |
---|---|
Spironolactone in the treatment of myasthenia gravis.
Topics: Aldosterone; Diuretics; Humans; Mineralocorticoid Receptor Antagonists; Myasthenia Gravis; Spironola | 1961 |
[Spirolactone].
Topics: Edema; Humans; Myasthenia Gravis; Paralysis; Spironolactone | 1962 |
[MYASTHENIA].
Topics: Ammonium Compounds; Blood; Cardiovascular Agents; Child; Diagnosis; Endocrinology; Ephedrine; Guanid | 1964 |
[EFFECT OF TRIAMTERENE ON MYASTHENIA GRAVIS].
Topics: Diuretics; Drug Therapy; Ions; Myasthenia Gravis; Pharmacology; Potassium; Pterins; Sodium; Sodium, | 1964 |
[TREATMENT OF NEUROMUSCULAR SYNDROMES WITH SPIROLACTONES].
Topics: Familial Mediterranean Fever; Humans; Myasthenia Gravis; Spironolactone; Syndrome; Toxicology | 1964 |
[MYASTHENIA AND SPIROLACTONE].
Topics: Blood Chemical Analysis; Calcium; Calcium, Dietary; Chlorides; Cholinesterase Inhibitors; Deglutitio | 1964 |
[HOW TO TREAT MYASTHENIA].
Topics: Ambenonium Chloride; Ephedrine; Humans; Muscle Weakness; Myasthenia Gravis; Neostigmine; Physostigmi | 1964 |
[PRACTICAL TREATMENT OF MYASTHENIA].
Topics: Adrenal Cortex Hormones; Cholinesterase Inhibitors; Drug Therapy; Humans; Muscle Weakness; Myastheni | 1964 |
[MYASTHENIA GRAVIS].
Topics: Ambenonium Chloride; Atropine; Diagnosis; Drug Therapy; Humans; Myasthenia Gravis; Neostigmine; Pral | 1965 |
[5 CASES OF MYASTHENIA TREATED WITH SPIRONOLACTONE (SC9420 LEPETIT)].
Topics: Humans; Muscle Weakness; Myasthenia Gravis; Spironolactone | 1964 |
MYASTHENIA GRAVIS: MEDICAL ASPECTS.
Topics: Acetylcholine; Botulism; Bromides; Cholinesterase Inhibitors; Decamethonium Compounds; Diagnosis; Di | 1965 |
[Preliminary note on the use of a spirolactone in the treatment of myasthenia].
Topics: Aldosterone; Humans; Mineralocorticoid Receptor Antagonists; Muscle Weakness; Myasthenia Gravis; Spi | 1962 |
[Myasthenia gravis and spironolactone].
Topics: Aldosterone; Humans; Mineralocorticoid Receptor Antagonists; Myasthenia Gravis; Progesterone; Spiron | 1962 |
[Apropos of a case of myasthenia gravis improved by spirolactones].
Topics: Aldosterone; Humans; Mineralocorticoid Receptor Antagonists; Myasthenia Gravis; Spironolactone | 1962 |
[Myasthenia gravis and pregnancy: clinical course and management of delivery and the postpartum phase].
Topics: Abortion, Therapeutic; Adult; Autoantibodies; Autoantigens; Cholinesterase Inhibitors; Delivery, Obs | 2006 |
[Treatment of myasthenia with the aldosterone antagonist spironolactone].
Topics: Cholinesterase Inhibitors; Female; Humans; Hyperkalemia; Middle Aged; Mineralocorticoid Receptor Ant | 1966 |
[Transient and curable myasthenia appearing 3 years after lower right thymectomy].
Topics: Female; Humans; Middle Aged; Myasthenia Gravis; Neostigmine; Postoperative Complications; Pyridostig | 1977 |
Results with ACTH and spironolactone in severe cases of myasthenia gravis.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Female; Humans; Intensive Care Units; Male; Mi | 1965 |
Treatment of severe myasthenia gravis with large doses of ACTH.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Cholinesterase Inhibitors; Female; Humans; Mal | 1966 |
[On motor end-plate diseases with special reference to myasthenia gravis].
Topics: Acetylcholine; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Antigen-Antibody React | 1965 |
[On the therapy of myasthenia gravis. (Presentation of a case)].
Topics: Adrenocorticotropic Hormone; Adult; Autoantibodies; Autoimmune Diseases; Female; Humans; Myasthenia | 1970 |
[Treatment of myasthenia with corticotropic hormones].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Delayed-Action Preparations; Female; Hu | 1972 |
[Treatment of myasthenia with adrencorticotrophins (ACTH and Synacthen). Apropos of 100 treatments in 25 patients].
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Cholinesterase Inhibitors; Evaluation Studies | 1972 |
The effect of aldactone-A on intracellular potassium in patients with myasthenia gravis.
Topics: Adult; Body Water; Cholinesterase Inhibitors; Evaluation Studies as Topic; Female; Humans; Male; Mid | 1973 |
[Treatment of myasthenia gravis in children].
Topics: Adolescent; Age Factors; Child; Female; Humans; Myasthenia Gravis; Neostigmine; Spironolactone; Thym | 1972 |
[Clinical studies on the urinary excretion of aldosterone in myasthenia gravis].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adult; Aldosterone; Ambenonium Chloride; Cat | 1967 |
[Treatment of myasthenia with spironolactone].
Topics: Adult; Female; Humans; Middle Aged; Myasthenia Gravis; Spironolactone | 1969 |
[On the diagnosis and therapy of myasthenia gravis pseudoparalytica].
Topics: Diagnosis, Differential; Female; Humans; Middle Aged; Myasthenia Gravis; Physostigmine; Spironolacto | 1969 |
[Use of spirolactone in treatment of myasthenia in pregnancy].
Topics: Female; Humans; Myasthenia Gravis; Pregnancy; Pregnancy Complications; Spironolactone | 1965 |